Works matching DE "VACCINE approval"
Results: 260
mRNA Vaccines Against SARS‐CoV‐2 Variants Delivered by Lipid Nanoparticles Based on Novel Ionizable Lipids.
- Published in:
- Advanced Functional Materials, 2022, v. 32, n. 39, p. 1, doi. 10.1002/adfm.202204692
- By:
- Publication type:
- Article
Cryo-EM structure of Sudan ebolavirus glycoprotein complexed with its human endosomal receptor NPC1.
- Published in:
- Communications Biology, 2025, v. 8, n. 1, p. 1, doi. 10.1038/s42003-025-07613-y
- By:
- Publication type:
- Article
Health Emergency Preparedness and Response Authority's (HERA) role in dealing with the monkeypox emergency in the European Union.
- Published in:
- Pharmacia (0428-0296), 2024, v. 71, n. 1, p. 1, doi. 10.3897/pharmacia.71.e117944
- By:
- Publication type:
- Article
Development and Evaluation of the Immunogenic Potential of an Unmodified Nucleoside mRNA Vaccine for Herpes Zoster.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 68, doi. 10.3390/vaccines13010068
- By:
- Publication type:
- Article
Platform Technology in Global Vaccine Regulation: Development, Applications, and Regulatory Strategies with Insights from China.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1436, doi. 10.3390/vaccines12121436
- By:
- Publication type:
- Article
Safety, Immunogenicity, and Efficacy of a Recombinant Vesicular Stomatitis Virus Vectored Vaccine Against Severe Fever with Thrombocytopenia Syndrome Virus and Heartland Bandavirus.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1403, doi. 10.3390/vaccines12121403
- By:
- Publication type:
- Article
Measuring the Vaccine Success Index: A Framework for Long-Term Economic Evaluation and Monitoring in the Case of Rotavirus Vaccination.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1265, doi. 10.3390/vaccines12111265
- By:
- Publication type:
- Article
Immunogenicity Analysis of Chikungunya Virus DNA Vaccine Based on Mutated Putative N-Linked Glycosylation Sites of the Envelope Protein.
- Published in:
- Vaccines, 2024, v. 12, n. 10, p. 1097, doi. 10.3390/vaccines12101097
- By:
- Publication type:
- Article
Formulation Attributes Impact Immune Profile of an Oral and Thermostable COVID-19 Subunit Vaccine.
- Published in:
- Vaccines, 2024, v. 12, n. 10, p. 1087, doi. 10.3390/vaccines12101087
- By:
- Publication type:
- Article
Navigating the Landscape of B Cell Mediated Immunity and Antibody Monitoring in SARS-CoV-2 Vaccine Efficacy: Tools, Strategies and Clinical Trial Insights.
- Published in:
- Vaccines, 2024, v. 12, n. 10, p. 1089, doi. 10.3390/vaccines12101089
- By:
- Publication type:
- Article
Malaria Vaccines: From the Past towards the mRNA Vaccine Era.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1452, doi. 10.3390/vaccines11091452
- By:
- Publication type:
- Article
Changes in the Epidemiology of Rubella: The Influence of Vaccine-Introducing Methods and COVID-19.
- Published in:
- Vaccines, 2023, v. 11, n. 8, p. 1358, doi. 10.3390/vaccines11081358
- By:
- Publication type:
- Article
Optimal Expression, Function, and Immunogenicity of an HIV-1 Vaccine Derived from the Approved Ebola Vaccine, rVSV-ZEBOV.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 977, doi. 10.3390/vaccines11050977
- By:
- Publication type:
- Article
Vaccine Candidates against Arenavirus Infections.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 635, doi. 10.3390/vaccines11030635
- By:
- Publication type:
- Article
Acceptance, Advocacy, and Perception of Health Care Providers on COVID-19 Vaccine: Comparing Early Stage of COVID-19 Vaccination with Latter Stage in the Eastern Region of Saudi Arabia.
- Published in:
- Vaccines, 2023, v. 11, n. 2, p. 488, doi. 10.3390/vaccines11020488
- By:
- Publication type:
- Article
Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status.
- Published in:
- Vaccines, 2023, v. 11, n. 2, p. 432, doi. 10.3390/vaccines11020432
- By:
- Publication type:
- Article
Humoral Immune Response to CoronaVac in Turkish Adults.
- Published in:
- Vaccines, 2023, v. 11, n. 2, p. 216, doi. 10.3390/vaccines11020216
- By:
- Publication type:
- Article
Early Real-World Data to Assess Benefits and Risks of COVID-19 Vaccines: A Systematic Review of Methods.
- Published in:
- Vaccines, 2022, v. 10, n. 11, p. 1896, doi. 10.3390/vaccines10111896
- By:
- Publication type:
- Article
Short-Term Adverse Effects Following Booster Dose of Inactivated-Virus vs. Adenoviral-Vector COVID-19 Vaccines in Algeria: A Cross-Sectional Study of the General Population.
- Published in:
- Vaccines, 2022, v. 10, n. 11, p. 1781, doi. 10.3390/vaccines10111781
- By:
- Publication type:
- Article
Transdermal Immunization with Microparticulate RSV-F Virus-like Particles Elicits Robust Immunity.
- Published in:
- Vaccines, 2022, v. 10, n. 4, p. N.PAG, doi. 10.3390/vaccines10040584
- By:
- Publication type:
- Article
Association of Vaccine Confidence and Hesitancy in Three Phases of COVID-19 Vaccine Approval and Introduction in Japan.
- Published in:
- Vaccines, 2022, v. 10, n. 3, p. 423, doi. 10.3390/vaccines10030423
- By:
- Publication type:
- Article
Determinants of COVID-19 Vaccinations among a State-Wide Year-Long Surveillance Initiative in a Conservative Southern State.
- Published in:
- Vaccines, 2022, v. 10, n. 3, p. 412, doi. 10.3390/vaccines10030412
- By:
- Publication type:
- Article
Efficacy and Safety of Heterologous Booster Vaccination after Ad5-nCoV (CanSino Biologics) Vaccine: A Preliminary Descriptive Study.
- Published in:
- Vaccines, 2022, v. 10, n. 3, p. 400, doi. 10.3390/vaccines10030400
- By:
- Publication type:
- Article
SARS-CoV-2–Specific Vaccine Candidates; the Contribution of Structural Vaccinology.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 236, doi. 10.3390/vaccines10020236
- By:
- Publication type:
- Article
Race-ethnicity and COVID-19 Vaccination Beliefs and Intentions: A Cross-Sectional Study among the General Population in the San Francisco Bay Area.
- Published in:
- Vaccines, 2021, v. 9, n. 12, p. 1406, doi. 10.3390/vaccines9121406
- By:
- Publication type:
- Article
Regional Differences in COVID-19 Vaccine Hesitancy in December 2020: A Natural Experiment in the French Working-Age Population.
- Published in:
- Vaccines, 2021, v. 9, n. 11, p. 1364, doi. 10.3390/vaccines9111364
- By:
- Publication type:
- Article
Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview.
- Published in:
- Vaccines, 2021, v. 9, n. 11, p. 1317, doi. 10.3390/vaccines9111317
- By:
- Publication type:
- Article
Prophylactic and Therapeutic EBV Vaccines: Major Scientific Obstacles, Historical Progress, and Future Direction.
- Published in:
- Vaccines, 2021, v. 9, n. 11, p. 1290, doi. 10.3390/vaccines9111290
- By:
- Publication type:
- Article
Chimeric Vaccines Based on Novel Insect-Specific Flaviviruses.
- Published in:
- Vaccines, 2021, v. 9, n. 11, p. 1230, doi. 10.3390/vaccines9111230
- By:
- Publication type:
- Article
The Role of Attitudes, Norms, and Efficacy on Shifting COVID-19 Vaccine Intentions: A Longitudinal Study of COVID-19 Vaccination Intentions in New Zealand.
- Published in:
- Vaccines, 2021, v. 9, n. 10, p. 1132, doi. 10.3390/vaccines9101132
- By:
- Publication type:
- Article
A Single Dose of a Hybrid hAdV5-Based Anti-COVID-19 Vaccine Induces a Long-Lasting Immune Response and Broad Coverage against VOC.
- Published in:
- Vaccines, 2021, v. 9, n. 10, p. 1106, doi. 10.3390/vaccines9101106
- By:
- Publication type:
- Article
The Long and Winding Road: Uptake, Acceptability, and Potential Influencing Factors of COVID-19 Vaccination in Austria.
- Published in:
- Vaccines, 2021, v. 9, n. 7, p. 790, doi. 10.3390/vaccines9070790
- By:
- Publication type:
- Article
Vaccination in PADs.
- Published in:
- Vaccines, 2021, v. 9, n. 6, p. 626, doi. 10.3390/vaccines9060626
- By:
- Publication type:
- Article
Asian-Origin Approved COVID-19 Vaccines and Current Status of COVID-19 Vaccination Program in Asia: A Critical Analysis.
- Published in:
- Vaccines, 2021, v. 9, n. 6, p. 600, doi. 10.3390/vaccines9060600
- By:
- Publication type:
- Article
Immuno-Informatics Analysis of Pakistan-Based HCV Subtype-3a for Chimeric Polypeptide Vaccine Design.
- Published in:
- Vaccines, 2021, v. 9, n. 3, p. 293, doi. 10.3390/vaccines9030293
- By:
- Publication type:
- Article
Comparison of immune activation of the COVID vaccines: ChAdOx1, BNT162b2, mRNA-1273, BBIBP-CorV, and Gam-COVID-Vac from serological human samples in Hungary showed higher protection after mRNA-based immunization.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2022, v. 26, n. 14, p. 5297
- By:
- Publication type:
- Article
The association of COVID-19 vaccine availability with mental health among adults in the United States.
- Published in:
- Frontiers in Psychiatry, 2022, v. 13, p. 1, doi. 10.3389/fpsyt.2022.970007
- By:
- Publication type:
- Article
Single-dose of a replication-competent adenovirus-vectored vaccine provides sterilizing protection against Rift Valley fever virus challenge.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.907675
- By:
- Publication type:
- Article
Progressive Host-Directed Strategies to Potentiate BCG Vaccination Against Tuberculosis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.944183
- By:
- Publication type:
- Article
Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.864718
- By:
- Publication type:
- Article
CLIC and membrane wound repair pathways enable pandemic norovirus entry and infection.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36398-z
- By:
- Publication type:
- Article
Immunopeptidomics-based design of mRNA vaccine formulations against Listeria monocytogenes.
- Published in:
- Nature Communications, 2022, v. 13, p. 1, doi. 10.1038/s41467-022-33721-y
- By:
- Publication type:
- Article
A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32232-0
- By:
- Publication type:
- Article
An intranasal ASO therapeutic targeting SARS-CoV-2.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32216-0
- By:
- Publication type:
- Article
PMA urges WHO to ensure acceptability of all its approved Covid19 vaccines for international travel.
- Published in:
- Pulse International, 2021, v. 22, n. 11, p. N.PAG
- Publication type:
- Article
Characterization of Argonaute-containing protein complexes in Leishmania-infected human macrophages.
- Published in:
- PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0303686
- By:
- Publication type:
- Article
Applying the Hornik & Woolf Approach to Identify Messaging Themes and Improve COVID-19 Vaccine Confidence Among Federally Qualified Health Centers' Workforce in Wisconsin.
- Published in:
- Journal of Health Communication, 2023, v. 28, n. 8, p. 507, doi. 10.1080/10810730.2023.2230929
- By:
- Publication type:
- Article
The Phony FDA Imprimatur.
- Published in:
- CounterPunch, 2021, p. 1
- By:
- Publication type:
- Article
Vaccine Platform Comparison: Protective Efficacy against Lethal Marburg Virus Challenge in the Hamster Model.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 15, p. 8516, doi. 10.3390/ijms25158516
- By:
- Publication type:
- Article
More Is Always Better Than One: The N-Terminal Domain of the Spike Protein as Another Emerging Target for Hampering the SARS-CoV-2 Attachment to Host Cells.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 12, p. 6462, doi. 10.3390/ijms22126462
- By:
- Publication type:
- Article